Variant report

Variant	esv3410635
Chromosome Location	chr7:100317416-100319614
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:197)
CpG islands
(count:671)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:197 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:100317386-100317494	HepG2	liver:	n/a	n/a
2	BHLHE40	chr7:100317405-100317649	HepG2	liver:	n/a	n/a
3	CEBPB	chr7:100317405-100317615	HepG2	liver:	n/a	n/a
4	CEBPD	chr7:100318176-100318854	HepG2	liver:	n/a	n/a
5	CHD2	chr7:100317434-100317533	HepG2	liver:	n/a	n/a
6	CTCF	chr7:100317620-100317770	AG04449	skin:	n/a	n/a
7	CTCF	chr7:100317740-100317890	AG09319	gingival:	n/a	n/a
8	CTCF	chr7:100317660-100317810	HPF	lung:	n/a	n/a
9	CTCF	chr7:100317680-100317830	HCPEpiC	choroid plexus:	n/a	n/a
10	CTCF	chr7:100317680-100317830	HUVEC	blood vessel:	n/a	n/a
11	CTCF	chr7:100317722-100317799	Pancreas_OC	pancreas:	n/a	n/a
12	CTCF	chr7:100317620-100317770	GM12873	blood:	n/a	n/a
13	CTCF	chr7:100317660-100317810	AG09319	gingival:	n/a	n/a
14	CTCF	chr7:100317680-100317830	BJ	skin:	n/a	n/a
15	CTCF	chr7:100317760-100317910	HFF-Myc	foreskin:	n/a	n/a
16	CTCF	chr7:100317617-100317938	A549	lung:	n/a	n/a
17	CTCF	chr7:100317607-100317948	MCF-7	breast:	n/a	n/a
18	CTCF	chr7:100317740-100317890	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr7:100317700-100317850	MCF-7	breast:	n/a	n/a
20	CTCF	chr7:100317740-100317890	BE2_C	brain:	n/a	n/a
21	CTCF	chr7:100317660-100317810	HCFaa	heart:	n/a	n/a
22	CTCF	chr7:100317680-100317830	WERI-Rb-1	eye:	n/a	n/a
23	CTCF	chr7:100317580-100317932	IMR90	lung:	n/a	n/a
24	CTCF	chr7:100317673-100317791	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr7:100317740-100317890	WI-38	lung:	n/a	n/a
26	CTCF	chr7:100317623-100317829	A549	lung:	n/a	n/a
27	CTCF	chr7:100317640-100317790	HMEC	breast:	n/a	n/a
28	CTCF	chr7:100317630-100317817	MCF-7	breast:	n/a	n/a
29	CTCF	chr7:100317720-100317870	A549	lung:	n/a	n/a
30	CTCF	chr7:100317591-100317986	A549	lung:	n/a	n/a
31	CTCF	chr7:100317692-100317798	HepG2	liver:	n/a	n/a
32	CTCF	chr7:100317660-100317810	SAEC	small airway:	n/a	n/a
33	CTCF	chr7:100317680-100317830	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr7:100317629-100317838	A549	lung:	n/a	n/a
35	CTCF	chr7:100317740-100317890	HEEpiC	esophagus:	n/a	n/a
36	CTCF	chr7:100317660-100317810	HMEC	breast:	n/a	n/a
37	CTCF	chr7:100317720-100317870	NB4	blood:	n/a	n/a
38	CTCF	chr7:100317680-100317830	SK-N-SH_RA	brain:	n/a	n/a
39	CTCF	chr7:100317620-100317770	HepG2	liver:	n/a	n/a
40	CTCF	chr7:100317660-100317810	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr7:100317653-100317837	Hela-S3	cervix:	n/a	n/a
42	CTCF	chr7:100317700-100317850	HAc	cerebellar:	n/a	n/a
43	CTCF	chr7:100318140-100318290	SK-N-SH_RA	brain:	n/a	chr7:100318258-100318267
44	CTCF	chr7:100317660-100317810	AG09309	skin:	n/a	n/a
45	CTCF	chr7:100317625-100317834	Gliobla	brain:	n/a	n/a
46	CTCF	chr7:100317640-100317766	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr7:100317724-100317786	HUVEC	blood vessel:	n/a	n/a
48	CTCF	chr7:100317740-100317890	HBMEC	blood vessel:	n/a	n/a
49	CTCF	chr7:100317620-100317770	HUVEC	blood vessel:	n/a	n/a
50	CTCF	chr7:100317700-100317850	HBMEC	blood vessel:	n/a	n/a

(count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:100318319-100318369	LNCaP	prostate:	n/a
2	chr7:100318319-100318369	GM12878	blood:	n/a
3	chr7:100318319-100318369	HIPEpiC	eye:	n/a
4	chr7:100317741-100317791	GM12878	blood:	n/a
5	chr7:100318718-100318768	BE2_C	brain:	n/a
6	chr7:100318239-100318289	HCPEpiC	choroid plexus:	n/a
7	chr7:100318239-100318289	HNPCEpiC	eye:	n/a
8	chr7:100318223-100318273	HNPCEpiC	eye:	n/a
9	chr7:100317741-100317791	SKMC	muscle:	n/a
10	chr7:100318319-100318369	Jurkat	blood:	n/a
11	chr7:100318239-100318289	SKMC	muscle:	n/a
12	chr7:100318626-100318676	PrEC	prostate:	n/a
13	chr7:100318190-100318240	CMK	blood:	n/a
14	chr7:100318194-100318244	HRE	kidney:	n/a
15	chr7:100318194-100318244	HIPEpiC	eye:	n/a
16	chr7:100318190-100318240	LNCaP	prostate:	n/a
17	chr7:100318319-100318369	A549	lung:	n/a
18	chr7:100318239-100318289	GM12891	blood:	n/a
19	chr7:100318194-100318244	PANC-1	pancreas:	n/a
20	chr7:100318718-100318768	HIPEpiC	eye:	n/a
21	chr7:100318190-100318240	SAEC	small airway:	n/a
22	chr7:100318080-100318130	HNPCEpiC	eye:	n/a
23	chr7:100318321-100318371	T-47D	breast:	n/a
24	chr7:100318239-100318289	PANC-1	pancreas:	n/a
25	chr7:100318626-100318676	CMK	blood:	n/a
26	chr7:100318239-100318289	HCM	heart:	n/a
27	chr7:100318080-100318130	AG09309	skin:	n/a
28	chr7:100318626-100318676	GM06990	blood:	n/a
29	chr7:100317741-100317791	U87	brain:	n/a
30	chr7:100318626-100318676	RPTEC	kidney:	n/a
31	chr7:100317741-100317791	AG04449	skin:	fetal
32	chr7:100318319-100318369	HRPEpiC	eye:	n/a
33	chr7:100318626-100318676	NHBE	bronchial:	n/a
34	chr7:100318223-100318273	CMK	blood:	n/a
35	chr7:100318626-100318676	Jurkat	blood:	n/a
36	chr7:100318718-100318768	T-47D	breast:	n/a
37	chr7:100318190-100318240	HCT-116	colon:	n/a
38	chr7:100318194-100318244	HL-60	blood:	n/a
39	chr7:100318239-100318289	SAEC	small airway:	n/a
40	chr7:100318319-100318369	PrEC	prostate:	n/a
41	chr7:100318718-100318768	AG10803	skin:	n/a
42	chr7:100318194-100318244	SAEC	small airway:	n/a
43	chr7:100318321-100318371	GM12878	blood:	n/a
44	chr7:100318080-100318130	PrEC	prostate:	n/a
45	chr7:100318194-100318244	SK-N-MC	brain:	n/a
46	chr7:100317741-100317791	ProgFib	skin:	n/a
47	chr7:100317741-100317791	HEK293	kidney:	embryo
48	chr7:100318239-100318289	NB4	blood:	n/a
49	chr7:100317741-100317791	SK-N-SH_RA	brain:	n/a
50	chr7:100318190-100318240	SKMC	muscle:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:100315257..100318069-chr7:100320272..100323098,2	MCF-7	breast:
2	chr7:100315107..100317886-chr7:100488286..100489805,2	MCF-7	breast:
3	chr7:100315279..100318194-chr7:100320126..100322658,3	K562	blood:
4	chr7:100288252..100292867-chr7:100319528..100322364,4	K562	blood:
5	chr7:100302051..100306591-chr7:100312993..100321692,11	MCF-7	breast:
6	chr7:100317313..100318403-chr7:100449405..100450273,4	MCF-7	breast:
7	chr7:100314177..100318194-chr7:100318771..100321626,3	K562	blood:
8	chr7:100314177..100318194-chr7:100318771..100321626,3	K562	blood:
9	chr7:100183516..100185859-chr7:100318860..100320461,2	MCF-7	breast:
10	chr7:100319576..100322114-chr7:100397770..100400557,3	MCF-7	breast:
11	chr7:100302553..100308135-chr7:100314195..100322207,16	MCF-7	breast:
12	chr7:100317495..100321039-chr7:100423744..100425687,3	MCF-7	breast:
13	chr7:100311308..100312814-chr7:100315076..100317499,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-EPO-1	chr7:100318312-100318821	expReg_chr7_6636_+

No data

Variant related genes	Relation type
EPO	TF binding region
EPO	CpG island
ENSG00000236305	chromatin interactions
ENSG00000106336	chromatin interactions
ENSG00000172336	chromatin interactions
ENSG00000077454	chromatin interactions
ENSG00000196411	chromatin interactions
ENSG00000146828	chromatin interactions

Extended variants
information (count: 80 )
Associated
traits (count: 94 )

Variant overlapped rSNPs/rCNVs (count:80 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369076362	chr7:100317490-100317491	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs574808264	chr7:100317523-100317524	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs541871088	chr7:100317562-100317563	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs561136222	chr7:100317582-100317583	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs531643733	chr7:100317599-100317600	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs543605228	chr7:100317600-100317601	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs186172689	chr7:100317606-100317607	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs532107435	chr7:100317667-100317668	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs547499487	chr7:100317708-100317709	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs556281148	chr7:100317794-100317795	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs201535171	chr7:100317795-100317796	Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs67532818	chr7:100317808-100317809	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs565525596	chr7:100317890-100317891	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs529657746	chr7:100317892-100317893	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs547900190	chr7:100317910-100317911	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs371642634	chr7:100317928-100317929	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs537389025	chr7:100318009-100318010	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs374690554	chr7:100318034-100318035	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs552347776	chr7:100318088-100318089	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs570738458	chr7:100318102-100318103	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs147801087	chr7:100318154-100318155	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs553394563	chr7:100318202-100318203	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs574855483	chr7:100318281-100318282	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs191419026	chr7:100318291-100318292	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs367762126	chr7:100318305-100318306	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs554028677	chr7:100318315-100318316	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
27	rs371400417	chr7:100318358-100318359	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
28	rs576397148	chr7:100318384-100318385	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
29	rs543789146	chr7:100318391-100318392	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	5 gene(s)	Overlapped CNVs	n/a
30	rs376713532	chr7:100318432-100318433	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
31	rs542975821	chr7:100318442-100318443	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
32	rs34144627	chr7:100318549-100318550	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
33	rs141701177	chr7:100318564-100318565	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
34	rs369468201	chr7:100318626-100318627	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
35	rs372062547	chr7:100318637-100318638	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
36	rs540884608	chr7:100318642-100318643	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
37	rs559371377	chr7:100318680-100318681	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
38	rs529760857	chr7:100318738-100318739	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
39	rs547772793	chr7:100318743-100318744	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
40	rs562990454	chr7:100318747-100318748	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
41	rs183591549	chr7:100318749-100318750	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
42	rs187459673	chr7:100318759-100318760	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
43	rs566438241	chr7:100318773-100318774	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
44	rs535187285	chr7:100318781-100318782	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
45	rs546879710	chr7:100318790-100318791	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
46	rs568503030	chr7:100318838-100318839	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs535619352	chr7:100318866-100318867	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs557391866	chr7:100318907-100318908	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs192596879	chr7:100318974-100318975	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs537328250	chr7:100318975-100318976	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:94)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100305000-100318000	Weak transcription	Right Atrium	heart
2	chr7:100305200-100318400	Weak transcription	Gastric	stomach
3	chr7:100316600-100317800	Weak transcription	Esophagus	oesophagus
4	chr7:100316600-100318400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr7:100316600-100318400	Enhancers	Liver	Liver
6	chr7:100316800-100318200	Bivalent Enhancer	Fetal Intestine Large	intestine
7	chr7:100317000-100318000	Flanking Active TSS	HepG2	liver
8	chr7:100317200-100317800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr7:100317200-100317800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
10	chr7:100317200-100319400	Bivalent Enhancer	Fetal Intestine Small	intestine
11	chr7:100317400-100317600	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
12	chr7:100317400-100318000	Bivalent Enhancer	Placenta	Placenta
13	chr7:100317400-100318200	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
14	chr7:100317400-100318800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
15	chr7:100317600-100319400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
16	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
17	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	H9 Cell Line	embryonic stem cell
18	chr7:100317800-100318000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
20	chr7:100317800-100318000	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr7:100317800-100318000	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
22	chr7:100317800-100318000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
23	chr7:100317800-100318000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr7:100317800-100318000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr7:100317800-100318000	Bivalent Enhancer	Adipose Nuclei	Adipose
26	chr7:100317800-100318000	Enhancers	Esophagus	oesophagus
27	chr7:100317800-100318000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 29	rectum
29	chr7:100317800-100318000	Active TSS	A549	lung
30	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	HSMM	muscle
31	chr7:100317800-100318000	Bivalent Enhancer	NH-A	brain
32	chr7:100317800-100318000	Flanking Bivalent TSS/Enh	NHEK	skin
33	chr7:100317800-100318000	Bivalent Enhancer	Osteobl	bone
34	chr7:100317800-100318200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr7:100317800-100318200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
36	chr7:100317800-100318200	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr7:100317800-100318200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr7:100317800-100318200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr7:100317800-100318200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr7:100317800-100318200	Bivalent Enhancer	Fetal Lung	lung
41	chr7:100317800-100318200	Bivalent/Poised TSS	NHDF-Ad	bronchial
42	chr7:100317800-100318600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr7:100317800-100318600	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
44	chr7:100317800-100318600	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr7:100317800-100318600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr7:100317800-100318600	Bivalent Enhancer	Stomach Mucosa	stomach
47	chr7:100317800-100318800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
48	chr7:100317800-100318800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
49	chr7:100317800-100318800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
50	chr7:100317800-100318800	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links